Relmada's depression drug fails to meet late-stage study goal

The drug, REL-1017, did not show statistically significant improvement in symptoms of depression when compared to a placebo

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/8BT6kyV